Metyrosine
Back to searchMolecule Structure
Scientific Name
Metyrosine
Description of the Drug
Metyrosine is a tyrosine 3-monooxygenase inhibitor used to treat excessive sympathetic stimulation in pheochromocytoma.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB00765
http://www.drugbank.ca/drugs/DB00765
Brand Name(s)
Demser
Company Owner(s)
Amneal Eu Ltd, Bausch Health Us Llc
Mechanism(s) Of Action
Target Name | Target Type | Action Type | Target ChEMBL ID |
---|---|---|---|
Tyrosine 3-hydroxylase | SINGLE PROTEIN | INHIBITOR | CHEMBL1969 |
Clinical Trial(s)
Unichem Links
SureChEMBL | SCHEMBL50398 | ||
PharmGKB | PA450487 | ||
Human Metabolome Database | HMDB0014903 | ||
DrugBank | DB00765 | ||
PubChem: Thomson Pharma | 15171600 | 15219928 | |
PubChem | 441350 | 6918925 | |
Mcule | MCULE-5340647798 | MCULE-4720986345 | |
Nikkaji | J9.465J | ||
EPA CompTox Dashboard | DTXSID6023315 | ||
DrugCentral | 1792 | ||
Metabolights | MTBLC6912 | ||
Brenda | 33637 | 224440 | 62197 |
ChemicalBook | CB2480716 | ||
Guide to Pharmacology | 6956 | ||
rxnorm | METYROSINE | DEMSER | |
KEGG Ligand | C07921 | ||
ChEBI | 6912 | ||
ZINC | ZINC000000000693 |